Association between the G-protein-coupled estrogen receptor 1 and prostate cancer in the Slovak population
Martina Mečiaková, Ján Kliment, Róbert Dušenka, Daniel Evin, Martina Knoško Brožová, Monika Kmeťová Sivoňová, Dušan Dobrota, Jana Jurečeková · 2026
Read Association between the G-protein-coupled estrogen receptor 1 and prostate cancer in the Slovak population by Martina Mečiaková, Ján Kliment, Róbert Dušenka, Daniel Evin, Martina Knoško Brožová, Monika Kmeťová Sivoňová, Dušan Dobrota, Jana Jurečeková (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13279688.txt.
Description
Martina Meciakova and colleagues report a 2026 study of an estrogen receptor gene and prostate cancer in Slovak men. Prostate cancer is the most diagnosed cancer in Slovak men and the third cause of their cancer death. The receptor, GPER1, passes fast estrogen signals and may serve as a drug target. Little was known on how gene variants in GPER1 shape cancer risk or traits.
Blood DNA came from seven hundred one patients and six hundred fifty nine healthy men. Three gene variants were typed by a targeted lab test. Gene use was also read in cancer tissue versus benign prostate tissue. One variant, rs3808350, went with higher cancer risk. The link ran strongest in patients with high Gleason scores, a grade of cancer vigour, and with spread to nodes or far sites. Other variants showed no clear link in the excerpt.
Catalog record
| CREATOR | Martina Mečiaková, Ján Kliment, Róbert Dušenka, Daniel Evin, Martina Knoško Brožová, Monika Kmeťová Sivoňová, Dušan Dobrota, Jana Jurečeková |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39917 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |